Launch of “Innovation to Startup” (I2Start) Pathway scheme

The National Health Innovation Centre Singapore, in collaboration with SPRING Singapore, is pleased to announce the launch of the “Innovation to Startup” (I2Start) Pathway scheme. This is an accelerated funding pathway to provide Singapore’s clinician scientists with a platform to develop a medtech innovation and then commercialise it via a startup company route.

The I2Start Pathway brings together two successful grant schemes: the NHIC Innovation to Develop (I2D) and the SPRING Technology Enterprise Commercialisation Scheme (TECS), to streamline the funding support.

We are seeking highly driven clinician-led project teams planning to start a medical device company. The team submits a single proposal to NHIC, and a joint NHIC-SPRING evaluation panel will assess the healthcare impact, market and business potential of the applications. Successful applicants will be awarded the NHIC I2D grant of $250K to the host institution, alongside a Letter of Intent from SPRING to support the continuation of the project via a start up vehicle, under their TECS grant.

 Interested applicants should contact your NHIC Healthcare Cluster Manager for the I2D-I2Start grant application template. The next closing date is Friday 7th April 2017.

For further details on the I2Start Pathway, please contact your NHIC Healthcare Cluster Manager or email

Healthcare Cluster

NHIC Cluster Manager


Sharron Bennett


Modukuru Naga Kishore


Michael Ho


Joshua Lim